img

Global Generic Sterile Injectable Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Generic Sterile Injectable Market Insights, Forecast to 2034

The generic sterile injectable are FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counterparts of these drugs and performs equally well. Thus, these Injectables are heavily in demand all the time and are used in majority of hospitals and clinics across the globe. However, due to the stringent FDA regulations for the production of these injectable, the rigorous demand satisfaction of these injectable has always been a constant challenge for the key players in the global generic sterile injectable market.

The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable.
Global Generic Sterile Injectable market is expected to reach to US$ 56020 million in 2024, with a positive growth of %, compared with US$ 51400 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Generic Sterile Injectable industry is evaluated to reach US$ 78570 million in 2029. The CAGR will be 5.8% during 2024 to 2029.
An alternative to the oral delivery mechanism is injectable drug delivery, which easily transports a drug dose through the bloodstream, thereby bypassing first-pass metabolism. There are some medications that would be entirely useless if delivered as capsules, as they would be killed by enzymes that digest food in the stomach. The insulin injection used in diabetes care is an example. Insulin is a protein. Therefore, if given as a tablet, the same enzymes that ferment food in the stomach would be digested. Therefore, as of today, there is no such term as an insulin tablet. Injectable allow the transport, directly into the bloodstream, of drugs manufactured in liquid form. The goal of the delivery of injectable drugs is to optimize patient compliance and reduce the frequency of dose administration without reducing medication efficacy. Due to deep vomiting, unconsciousness or having a cancer lining in the upper part of their dietary canal, it may be impossible to take tablets for certain patients. Therefore, injection options are available for most oral medications. The increasing prevalence of such metabolic disease aids in the overall growth in the sterile injectable market.

Report Covers
This report presents an overview of global Generic Sterile Injectable market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Generic Sterile Injectable market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


3M
Baxter Inc
Fresenius Kabi
Pfizer/Hospira
Novartis/Sandoz
Teva
Hikma
Sun Pharma
Dr. Reddy’s
Mylan
AstraZeneca Plc
Merck & Co., Inc
Hellberg Safety Ab
Segment by Type
Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Vaccines
Others

Segment by Application


Hospitals
Pharmacies
Online Pharmacies

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Generic Sterile Injectable plant distribution, commercial date of Generic Sterile Injectable, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Generic Sterile Injectable introduction, etc. Generic Sterile Injectable Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Generic Sterile Injectable
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Generic Sterile Injectable Product Introduction
1.2 Market by Type
1.2.1 Global Generic Sterile Injectable Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Cytokines
1.2.4 Insulin
1.2.5 Peptide Hormones
1.2.6 Vaccines
1.2.7 Others
1.3 Market by Application
1.3.1 Global Generic Sterile Injectable Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Generic Sterile Injectable Sales Estimates and Forecasts 2018-2029
2.2 Global Generic Sterile Injectable Revenue by Region
2.2.1 Global Generic Sterile Injectable Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Generic Sterile Injectable Revenue by Region (2018-2024)
2.2.3 Global Generic Sterile Injectable Revenue by Region (2024-2029)
2.2.4 Global Generic Sterile Injectable Revenue Market Share by Region (2018-2029)
2.3 Global Generic Sterile Injectable Sales Estimates and Forecasts 2018-2029
2.4 Global Generic Sterile Injectable Sales by Region
2.4.1 Global Generic Sterile Injectable Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Generic Sterile Injectable Sales by Region (2018-2024)
2.4.3 Global Generic Sterile Injectable Sales by Region (2024-2029)
2.4.4 Global Generic Sterile Injectable Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Generic Sterile Injectable Sales by Manufacturers
3.1.1 Global Generic Sterile Injectable Sales by Manufacturers (2018-2024)
3.1.2 Global Generic Sterile Injectable Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Generic Sterile Injectable in 2022
3.2 Global Generic Sterile Injectable Revenue by Manufacturers
3.2.1 Global Generic Sterile Injectable Revenue by Manufacturers (2018-2024)
3.2.2 Global Generic Sterile Injectable Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Generic Sterile Injectable Revenue in 2022
3.3 Global Key Players of Generic Sterile Injectable, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Generic Sterile Injectable Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Generic Sterile Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Generic Sterile Injectable, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Generic Sterile Injectable, Product Offered and Application
3.8 Global Key Manufacturers of Generic Sterile Injectable, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Generic Sterile Injectable Sales by Type
4.1.1 Global Generic Sterile Injectable Historical Sales by Type (2018-2024)
4.1.2 Global Generic Sterile Injectable Forecasted Sales by Type (2024-2029)
4.1.3 Global Generic Sterile Injectable Sales Market Share by Type (2018-2029)
4.2 Global Generic Sterile Injectable Revenue by Type
4.2.1 Global Generic Sterile Injectable Historical Revenue by Type (2018-2024)
4.2.2 Global Generic Sterile Injectable Forecasted Revenue by Type (2024-2029)
4.2.3 Global Generic Sterile Injectable Revenue Market Share by Type (2018-2029)
4.3 Global Generic Sterile Injectable Price by Type
4.3.1 Global Generic Sterile Injectable Price by Type (2018-2024)
4.3.2 Global Generic Sterile Injectable Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Generic Sterile Injectable Sales by Application
5.1.1 Global Generic Sterile Injectable Historical Sales by Application (2018-2024)
5.1.2 Global Generic Sterile Injectable Forecasted Sales by Application (2024-2029)
5.1.3 Global Generic Sterile Injectable Sales Market Share by Application (2018-2029)
5.2 Global Generic Sterile Injectable Revenue by Application
5.2.1 Global Generic Sterile Injectable Historical Revenue by Application (2018-2024)
5.2.2 Global Generic Sterile Injectable Forecasted Revenue by Application (2024-2029)
5.2.3 Global Generic Sterile Injectable Revenue Market Share by Application (2018-2029)
5.3 Global Generic Sterile Injectable Price by Application
5.3.1 Global Generic Sterile Injectable Price by Application (2018-2024)
5.3.2 Global Generic Sterile Injectable Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Generic Sterile Injectable Market Size by Type
6.1.1 US & Canada Generic Sterile Injectable Sales by Type (2018-2029)
6.1.2 US & Canada Generic Sterile Injectable Revenue by Type (2018-2029)
6.2 US & Canada Generic Sterile Injectable Market Size by Application
6.2.1 US & Canada Generic Sterile Injectable Sales by Application (2018-2029)
6.2.2 US & Canada Generic Sterile Injectable Revenue by Application (2018-2029)
6.3 US & Canada Generic Sterile Injectable Market Size by Country
6.3.1 US & Canada Generic Sterile Injectable Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Generic Sterile Injectable Sales by Country (2018-2029)
6.3.3 US & Canada Generic Sterile Injectable Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Generic Sterile Injectable Market Size by Type
7.1.1 Europe Generic Sterile Injectable Sales by Type (2018-2029)
7.1.2 Europe Generic Sterile Injectable Revenue by Type (2018-2029)
7.2 Europe Generic Sterile Injectable Market Size by Application
7.2.1 Europe Generic Sterile Injectable Sales by Application (2018-2029)
7.2.2 Europe Generic Sterile Injectable Revenue by Application (2018-2029)
7.3 Europe Generic Sterile Injectable Market Size by Country
7.3.1 Europe Generic Sterile Injectable Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Generic Sterile Injectable Sales by Country (2018-2029)
7.3.3 Europe Generic Sterile Injectable Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Generic Sterile Injectable Market Size
8.1.1 China Generic Sterile Injectable Sales (2018-2029)
8.1.2 China Generic Sterile Injectable Revenue (2018-2029)
8.2 China Generic Sterile Injectable Market Size by Application
8.2.1 China Generic Sterile Injectable Sales by Application (2018-2029)
8.2.2 China Generic Sterile Injectable Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Generic Sterile Injectable Market Size by Type
9.1.1 Asia Generic Sterile Injectable Sales by Type (2018-2029)
9.1.2 Asia Generic Sterile Injectable Revenue by Type (2018-2029)
9.2 Asia Generic Sterile Injectable Market Size by Application
9.2.1 Asia Generic Sterile Injectable Sales by Application (2018-2029)
9.2.2 Asia Generic Sterile Injectable Revenue by Application (2018-2029)
9.3 Asia Generic Sterile Injectable Sales by Region
9.3.1 Asia Generic Sterile Injectable Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Generic Sterile Injectable Revenue by Region (2018-2029)
9.3.3 Asia Generic Sterile Injectable Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Generic Sterile Injectable Market Size by Type
10.1.1 Middle East, Africa and Latin America Generic Sterile Injectable Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Generic Sterile Injectable Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Generic Sterile Injectable Market Size by Application
10.2.1 Middle East, Africa and Latin America Generic Sterile Injectable Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Generic Sterile Injectable Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Generic Sterile Injectable Sales by Country
10.3.1 Middle East, Africa and Latin America Generic Sterile Injectable Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Generic Sterile Injectable Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Generic Sterile Injectable Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 3M
11.1.1 3M Company Information
11.1.2 3M Overview
11.1.3 3M Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 3M Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 3M Recent Developments
11.2 Baxter Inc
11.2.1 Baxter Inc Company Information
11.2.2 Baxter Inc Overview
11.2.3 Baxter Inc Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Baxter Inc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Inc Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Information
11.3.2 Fresenius Kabi Overview
11.3.3 Fresenius Kabi Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Fresenius Kabi Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius Kabi Recent Developments
11.4 Pfizer/Hospira
11.4.1 Pfizer/Hospira Company Information
11.4.2 Pfizer/Hospira Overview
11.4.3 Pfizer/Hospira Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Pfizer/Hospira Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer/Hospira Recent Developments
11.5 Novartis/Sandoz
11.5.1 Novartis/Sandoz Company Information
11.5.2 Novartis/Sandoz Overview
11.5.3 Novartis/Sandoz Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Novartis/Sandoz Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis/Sandoz Recent Developments
11.6 Teva
11.6.1 Teva Company Information
11.6.2 Teva Overview
11.6.3 Teva Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Teva Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Recent Developments
11.7 Hikma
11.7.1 Hikma Company Information
11.7.2 Hikma Overview
11.7.3 Hikma Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Hikma Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hikma Recent Developments
11.8 Sun Pharma
11.8.1 Sun Pharma Company Information
11.8.2 Sun Pharma Overview
11.8.3 Sun Pharma Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Sun Pharma Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sun Pharma Recent Developments
11.9 Dr. Reddy’s
11.9.1 Dr. Reddy’s Company Information
11.9.2 Dr. Reddy’s Overview
11.9.3 Dr. Reddy’s Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Dr. Reddy’s Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dr. Reddy’s Recent Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Overview
11.10.3 Mylan Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Mylan Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan Recent Developments
11.11 AstraZeneca Plc
11.11.1 AstraZeneca Plc Company Information
11.11.2 AstraZeneca Plc Overview
11.11.3 AstraZeneca Plc Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 AstraZeneca Plc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 AstraZeneca Plc Recent Developments
11.12 Merck & Co., Inc
11.12.1 Merck & Co., Inc Company Information
11.12.2 Merck & Co., Inc Overview
11.12.3 Merck & Co., Inc Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Merck & Co., Inc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Merck & Co., Inc Recent Developments
11.13 Hellberg Safety Ab
11.13.1 Hellberg Safety Ab Company Information
11.13.2 Hellberg Safety Ab Overview
11.13.3 Hellberg Safety Ab Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Hellberg Safety Ab Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hellberg Safety Ab Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Generic Sterile Injectable Industry Chain Analysis
12.2 Generic Sterile Injectable Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Generic Sterile Injectable Production Mode & Process
12.4 Generic Sterile Injectable Sales and Marketing
12.4.1 Generic Sterile Injectable Sales Channels
12.4.2 Generic Sterile Injectable Distributors
12.5 Generic Sterile Injectable Customers
13 Market Dynamics
13.1 Generic Sterile Injectable Industry Trends
13.2 Generic Sterile Injectable Market Drivers
13.3 Generic Sterile Injectable Market Challenges
13.4 Generic Sterile Injectable Market Restraints
14 Key Findings in The Global Generic Sterile Injectable Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Generic Sterile Injectable Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibodies
Table 3. Major Manufacturers of Cytokines
Table 4. Major Manufacturers of Insulin
Table 5. Major Manufacturers of Peptide Hormones
Table 6. Major Manufacturers of Vaccines
Table 7. Major Manufacturers of Others
Table 8. Global Generic Sterile Injectable Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Generic Sterile Injectable Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Generic Sterile Injectable Revenue by Region (2018-2024) & (US$ Million)
Table 11. Global Generic Sterile Injectable Revenue by Region (2024-2029) & (US$ Million)
Table 12. Global Generic Sterile Injectable Revenue Market Share by Region (2018-2024)
Table 13. Global Generic Sterile Injectable Revenue Market Share by Region (2024-2029)
Table 14. Global Generic Sterile Injectable Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 15. Global Generic Sterile Injectable Sales by Region (2018-2024) & (K Units)
Table 16. Global Generic Sterile Injectable Sales by Region (2024-2029) & (K Units)
Table 17. Global Generic Sterile Injectable Sales Market Share by Region (2018-2024)
Table 18. Global Generic Sterile Injectable Sales Market Share by Region (2024-2029)
Table 19. Global Generic Sterile Injectable Sales by Manufacturers (2018-2024) & (K Units)
Table 20. Global Generic Sterile Injectable Sales Share by Manufacturers (2018-2024)
Table 21. Global Generic Sterile Injectable Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 22. Global Generic Sterile Injectable Revenue Share by Manufacturers (2018-2024)
Table 23. Global Key Players of Generic Sterile Injectable, Industry Ranking, 2021 VS 2022 VS 2024
Table 24. Generic Sterile Injectable Price by Manufacturers 2018-2024 (USD/Unit)
Table 25. Global Generic Sterile Injectable Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Generic Sterile Injectable by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Sterile Injectable as of 2022)
Table 27. Global Key Manufacturers of Generic Sterile Injectable, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Generic Sterile Injectable, Product Offered and Application
Table 29. Global Key Manufacturers of Generic Sterile Injectable, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Generic Sterile Injectable Sales by Type (2018-2024) & (K Units)
Table 32. Global Generic Sterile Injectable Sales by Type (2024-2029) & (K Units)
Table 33. Global Generic Sterile Injectable Sales Share by Type (2018-2024)
Table 34. Global Generic Sterile Injectable Sales Share by Type (2024-2029)
Table 35. Global Generic Sterile Injectable Revenue by Type (2018-2024) & (US$ Million)
Table 36. Global Generic Sterile Injectable Revenue by Type (2024-2029) & (US$ Million)
Table 37. Global Generic Sterile Injectable Revenue Share by Type (2018-2024)
Table 38. Global Generic Sterile Injectable Revenue Share by Type (2024-2029)
Table 39. Generic Sterile Injectable Price by Type (2018-2024) & (USD/Unit)
Table 40. Global Generic Sterile Injectable Price Forecast by Type (2024-2029) & (USD/Unit)
Table 41. Global Generic Sterile Injectable Sales by Application (2018-2024) & (K Units)
Table 42. Global Generic Sterile Injectable Sales by Application (2024-2029) & (K Units)
Table 43. Global Generic Sterile Injectable Sales Share by Application (2018-2024)
Table 44. Global Generic Sterile Injectable Sales Share by Application (2024-2029)
Table 45. Global Generic Sterile Injectable Revenue by Application (2018-2024) & (US$ Million)
Table 46. Global Generic Sterile Injectable Revenue by Application (2024-2029) & (US$ Million)
Table 47. Global Generic Sterile Injectable Revenue Share by Application (2018-2024)
Table 48. Global Generic Sterile Injectable Revenue Share by Application (2024-2029)
Table 49. Generic Sterile Injectable Price by Application (2018-2024) & (USD/Unit)
Table 50. Global Generic Sterile Injectable Price Forecast by Application (2024-2029) & (USD/Unit)
Table 51. US & Canada Generic Sterile Injectable Sales by Type (2018-2024) & (K Units)
Table 52. US & Canada Generic Sterile Injectable Sales by Type (2024-2029) & (K Units)
Table 53. US & Canada Generic Sterile Injectable Revenue by Type (2018-2024) & (US$ Million)
Table 54. US & Canada Generic Sterile Injectable Revenue by Type (2024-2029) & (US$ Million)
Table 55. US & Canada Generic Sterile Injectable Sales by Application (2018-2024) & (K Units)
Table 56. US & Canada Generic Sterile Injectable Sales by Application (2024-2029) & (K Units)
Table 57. US & Canada Generic Sterile Injectable Revenue by Application (2018-2024) & (US$ Million)
Table 58. US & Canada Generic Sterile Injectable Revenue by Application (2024-2029) & (US$ Million)
Table 59. US & Canada Generic Sterile Injectable Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 60. US & Canada Generic Sterile Injectable Revenue by Country (2018-2024) & (US$ Million)
Table 61. US & Canada Generic Sterile Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 62. US & Canada Generic Sterile Injectable Sales by Country (2018-2024) & (K Units)
Table 63. US & Canada Generic Sterile Injectable Sales by Country (2024-2029) & (K Units)
Table 64. Europe Generic Sterile Injectable Sales by Type (2018-2024) & (K Units)
Table 65. Europe Generic Sterile Injectable Sales by Type (2024-2029) & (K Units)
Table 66. Europe Generic Sterile Injectable Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Generic Sterile Injectable Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Generic Sterile Injectable Sales by Application (2018-2024) & (K Units)
Table 69. Europe Generic Sterile Injectable Sales by Application (2024-2029) & (K Units)
Table 70. Europe Generic Sterile Injectable Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Generic Sterile Injectable Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Generic Sterile Injectable Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Generic Sterile Injectable Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Generic Sterile Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Generic Sterile Injectable Sales by Country (2018-2024) & (K Units)
Table 76. Europe Generic Sterile Injectable Sales by Country (2024-2029) & (K Units)
Table 77. China Generic Sterile Injectable Sales by Type (2018-2024) & (K Units)
Table 78. China Generic Sterile Injectable Sales by Type (2024-2029) & (K Units)
Table 79. China Generic Sterile Injectable Revenue by Type (2018-2024) & (US$ Million)
Table 80. China Generic Sterile Injectable Revenue by Type (2024-2029) & (US$ Million)
Table 81. China Generic Sterile Injectable Sales by Application (2018-2024) & (K Units)
Table 82. China Generic Sterile Injectable Sales by Application (2024-2029) & (K Units)
Table 83. China Generic Sterile Injectable Revenue by Application (2018-2024) & (US$ Million)
Table 84. China Generic Sterile Injectable Revenue by Application (2024-2029) & (US$ Million)
Table 85. Asia Generic Sterile Injectable Sales by Type (2018-2024) & (K Units)
Table 86. Asia Generic Sterile Injectable Sales by Type (2024-2029) & (K Units)
Table 87. Asia Generic Sterile Injectable Revenue by Type (2018-2024) & (US$ Million)
Table 88. Asia Generic Sterile Injectable Revenue by Type (2024-2029) & (US$ Million)
Table 89. Asia Generic Sterile Injectable Sales by Application (2018-2024) & (K Units)
Table 90. Asia Generic Sterile Injectable Sales by Application (2024-2029) & (K Units)
Table 91. Asia Generic Sterile Injectable Revenue by Application (2018-2024) & (US$ Million)
Table 92. Asia Generic Sterile Injectable Revenue by Application (2024-2029) & (US$ Million)
Table 93. Asia Generic Sterile Injectable Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 94. Asia Generic Sterile Injectable Revenue by Region (2018-2024) & (US$ Million)
Table 95. Asia Generic Sterile Injectable Revenue by Region (2024-2029) & (US$ Million)
Table 96. Asia Generic Sterile Injectable Sales by Region (2018-2024) & (K Units)
Table 97. Asia Generic Sterile Injectable Sales by Region (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Generic Sterile Injectable Sales by Type (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Generic Sterile Injectable Sales by Type (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Generic Sterile Injectable Revenue by Type (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Generic Sterile Injectable Revenue by Type (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Generic Sterile Injectable Sales by Application (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Generic Sterile Injectable Sales by Application (2024-2029) & (K Units)
Table 104. Middle East, Africa and Latin America Generic Sterile Injectable Revenue by Application (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Generic Sterile Injectable Revenue by Application (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Generic Sterile Injectable Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 107. Middle East, Africa and Latin America Generic Sterile Injectable Revenue by Country (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Generic Sterile Injectable Revenue by Country (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Generic Sterile Injectable Sales by Country (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Generic Sterile Injectable Sales by Country (2024-2029) & (K Units)
Table 111. 3M Company Information
Table 112. 3M Description and Major Businesses
Table 113. 3M Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 114. 3M Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. 3M Recent Developments
Table 116. Baxter Inc Company Information
Table 117. Baxter Inc Description and Major Businesses
Table 118. Baxter Inc Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 119. Baxter Inc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Baxter Inc Recent Developments
Table 121. Fresenius Kabi Company Information
Table 122. Fresenius Kabi Description and Major Businesses
Table 123. Fresenius Kabi Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 124. Fresenius Kabi Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Fresenius Kabi Recent Developments
Table 126. Pfizer/Hospira Company Information
Table 127. Pfizer/Hospira Description and Major Businesses
Table 128. Pfizer/Hospira Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 129. Pfizer/Hospira Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Pfizer/Hospira Recent Developments
Table 131. Novartis/Sandoz Company Information
Table 132. Novartis/Sandoz Description and Major Businesses
Table 133. Novartis/Sandoz Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 134. Novartis/Sandoz Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Novartis/Sandoz Recent Developments
Table 136. Teva Company Information
Table 137. Teva Description and Major Businesses
Table 138. Teva Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 139. Teva Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Teva Recent Developments
Table 141. Hikma Company Information
Table 142. Hikma Description and Major Businesses
Table 143. Hikma Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 144. Hikma Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Hikma Recent Developments
Table 146. Sun Pharma Company Information
Table 147. Sun Pharma Description and Major Businesses
Table 148. Sun Pharma Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 149. Sun Pharma Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Sun Pharma Recent Developments
Table 151. Dr. Reddy’s Company Information
Table 152. Dr. Reddy’s Description and Major Businesses
Table 153. Dr. Reddy’s Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 154. Dr. Reddy’s Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Dr. Reddy’s Recent Developments
Table 156. Mylan Company Information
Table 157. Mylan Description and Major Businesses
Table 158. Mylan Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 159. Mylan Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Mylan Recent Developments
Table 161. AstraZeneca Plc Company Information
Table 162. AstraZeneca Plc Description and Major Businesses
Table 163. AstraZeneca Plc Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 164. AstraZeneca Plc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. AstraZeneca Plc Recent Developments
Table 166. Merck & Co., Inc Company Information
Table 167. Merck & Co., Inc Description and Major Businesses
Table 168. Merck & Co., Inc Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 169. Merck & Co., Inc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Merck & Co., Inc Recent Developments
Table 171. Hellberg Safety Ab Company Information
Table 172. Hellberg Safety Ab Description and Major Businesses
Table 173. Hellberg Safety Ab Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 174. Hellberg Safety Ab Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Hellberg Safety Ab Recent Developments
Table 176. Key Raw Materials Lists
Table 177. Raw Materials Key Suppliers Lists
Table 178. Generic Sterile Injectable Distributors List
Table 179. Generic Sterile Injectable Customers List
Table 180. Generic Sterile Injectable Market Trends
Table 181. Generic Sterile Injectable Market Drivers
Table 182. Generic Sterile Injectable Market Challenges
Table 183. Generic Sterile Injectable Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Generic Sterile Injectable Product Picture
Figure 2. Global Generic Sterile Injectable Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Generic Sterile Injectable Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Cytokines Product Picture
Figure 6. Insulin Product Picture
Figure 7. Peptide Hormones Product Picture
Figure 8. Vaccines Product Picture
Figure 9. Others Product Picture
Figure 10. Global Generic Sterile Injectable Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Generic Sterile Injectable Market Share by Application in 2022 & 2029
Figure 12. Hospitals
Figure 13. Pharmacies
Figure 14. Online Pharmacies
Figure 15. Generic Sterile Injectable Report Years Considered
Figure 16. Global Generic Sterile Injectable Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Generic Sterile Injectable Revenue 2018-2029 (US$ Million)
Figure 18. Global Generic Sterile Injectable Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 19. Global Generic Sterile Injectable Revenue Market Share by Region (2018-2029)
Figure 20. Global Generic Sterile Injectable Sales 2018-2029 ((K Units)
Figure 21. Global Generic Sterile Injectable Sales Market Share by Region (2018-2029)
Figure 22. US & Canada Generic Sterile Injectable Sales YoY (2018-2029) & (K Units)
Figure 23. US & Canada Generic Sterile Injectable Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Europe Generic Sterile Injectable Sales YoY (2018-2029) & (K Units)
Figure 25. Europe Generic Sterile Injectable Revenue YoY (2018-2029) & (US$ Million)
Figure 26. China Generic Sterile Injectable Sales YoY (2018-2029) & (K Units)
Figure 27. China Generic Sterile Injectable Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Asia (excluding China) Generic Sterile Injectable Sales YoY (2018-2029) & (K Units)
Figure 29. Asia (excluding China) Generic Sterile Injectable Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Generic Sterile Injectable Sales YoY (2018-2029) & (K Units)
Figure 31. Middle East, Africa and Latin America Generic Sterile Injectable Revenue YoY (2018-2029) & (US$ Million)
Figure 32. The Generic Sterile Injectable Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Generic Sterile Injectable in the World: Market Share by Generic Sterile Injectable Revenue in 2022
Figure 34. Global Generic Sterile Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Generic Sterile Injectable Sales Market Share by Type (2018-2029)
Figure 36. Global Generic Sterile Injectable Revenue Market Share by Type (2018-2029)
Figure 37. Global Generic Sterile Injectable Sales Market Share by Application (2018-2029)
Figure 38. Global Generic Sterile Injectable Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Generic Sterile Injectable Sales Market Share by Type (2018-2029)
Figure 40. US & Canada Generic Sterile Injectable Revenue Market Share by Type (2018-2029)
Figure 41. US & Canada Generic Sterile Injectable Sales Market Share by Application (2018-2029)
Figure 42. US & Canada Generic Sterile Injectable Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Generic Sterile Injectable Revenue Share by Country (2018-2029)
Figure 44. US & Canada Generic Sterile Injectable Sales Share by Country (2018-2029)
Figure 45. U.S. Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 46. Canada Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 47. Europe Generic Sterile Injectable Sales Market Share by Type (2018-2029)
Figure 48. Europe Generic Sterile Injectable Revenue Market Share by Type (2018-2029)
Figure 49. Europe Generic Sterile Injectable Sales Market Share by Application (2018-2029)
Figure 50. Europe Generic Sterile Injectable Revenue Market Share by Application (2018-2029)
Figure 51. Europe Generic Sterile Injectable Revenue Share by Country (2018-2029)
Figure 52. Europe Generic Sterile Injectable Sales Share by Country (2018-2029)
Figure 53. Germany Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 54. France Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 58. China Generic Sterile Injectable Sales Market Share by Type (2018-2029)
Figure 59. China Generic Sterile Injectable Revenue Market Share by Type (2018-2029)
Figure 60. China Generic Sterile Injectable Sales Market Share by Application (2018-2029)
Figure 61. China Generic Sterile Injectable Revenue Market Share by Application (2018-2029)
Figure 62. Asia Generic Sterile Injectable Sales Market Share by Type (2018-2029)
Figure 63. Asia Generic Sterile Injectable Revenue Market Share by Type (2018-2029)
Figure 64. Asia Generic Sterile Injectable Sales Market Share by Application (2018-2029)
Figure 65. Asia Generic Sterile Injectable Revenue Market Share by Application (2018-2029)
Figure 66. Asia Generic Sterile Injectable Revenue Share by Region (2018-2029)
Figure 67. Asia Generic Sterile Injectable Sales Share by Region (2018-2029)
Figure 68. Japan Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 69. South Korea Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 70. China Taiwan Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 71. Southeast Asia Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 72. India Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Generic Sterile Injectable Sales Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Generic Sterile Injectable Revenue Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Generic Sterile Injectable Sales Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Generic Sterile Injectable Revenue Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Generic Sterile Injectable Revenue Share by Country (2018-2029)
Figure 78. Middle East, Africa and Latin America Generic Sterile Injectable Sales Share by Country (2018-2029)
Figure 79. Brazil Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 80. Mexico Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 81. Turkey Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 82. Israel Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 83. GCC Countries Generic Sterile Injectable Revenue (2018-2029) & (US$ Million)
Figure 84. Generic Sterile Injectable Value Chain
Figure 85. Generic Sterile Injectable Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed